Compared to the CRA group, the higher serum levels of CAP and ALT in NAFLD group, and the higher serum levels of CAP and AST in NAFLD&CRA group were observed (all P < 0.05). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.